PBYI - Puma Biotechnology Inc
IEX Last Trade
2.51
0.060 2.390%
Share volume: 328,427
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.45
0.06
2.45%
Fundamental analysis
33%
Profitability
55%
Dept financing
23%
Liquidity
26%
Performance
16%
Performance
5 Days
-1.57%
1 Month
-30.94%
3 Months
-34.38%
6 Months
-62.12%
1 Year
-31.79%
2 Year
-9.09%
Key data
Stock price
$2.51
DAY RANGE
N/A - N/A
52 WEEK RANGE
$2.13 - $7.73
52 WEEK CHANGE
-$0.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO:
Region: US
Website: pumabiotechnology.com
Employees: 292
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: pumabiotechnology.com
Employees: 292
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Recent news